Instil Bio, Inc. (TIL) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$36.62M | +34.3% |
| 2024 | -$55.70M | +32.1% |
| 2023 | -$82.03M | +54.5% |
| 2022 | -$180.16M | -47.5% |
| 2021 | -$122.14M | -312.4% |
| 2020 | -$29.62M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$36.62M | +34.3% |
| 2024 | -$55.70M | +32.1% |
| 2023 | -$82.03M | +54.5% |
| 2022 | -$180.16M | -47.5% |
| 2021 | -$122.14M | -312.4% |
| 2020 | -$29.62M | — |